0
Adamas Pharmaceuticals Inc
- 51-200 Employees
- Based in Emeryville, California
Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company’s lead product candidate ADS-5102, which completed the Phase II/III clinical trial for the treatment of Parkinson's disease, known as levodopa induced dyskinesia.
Adamas Pharmaceuticals Inc
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Report Locked. Adamas Pharmaceuticals Inc has reached its limit for free report views.
